Dying for Work Dying for Work
Close to 3,000 progressive activists from all walks of life joined Jim Hightower for his third "Rolling Thunder/Down-Home Democracy Tour" in Tucson on July 26.
Jul 31, 2002 / Feature / Tom Hayden
Brits and Drugs Brits and Drugs
"Tell me about the hash bars." "OK, what do you want to know?" "It's legal there, right?" "It's legal, but it ain't 100 percent legal."
Jul 31, 2002 / Feature / Stacey Butterfield
Another Bankrupt Idea From Congress Another Bankrupt Idea From Congress
Thou hast taken usury and increase, and thou hast greedily gained of thy neighbor by extortion, and hast forgotten me, saith the Lord God.
Jul 31, 2002 / Column / Robert Scheer
Springsteen Rising: Preparing for 9/11-Plus-One Springsteen Rising: Preparing for 9/11-Plus-One
September 11-Plus-One approaches. And so does remembrance and commemoration. Media envoys will visit with survivors and relatives of those murdered that awf...
Jul 30, 2002 / David Corn
The Year (’97) in Corporate Crime The Year (’97) in Corporate Crime
Research support provided by the Investigative Fund of the Nation Institute.
Jul 29, 2002 / Feature / Robert Sherrill
House Approves Fast Track House Approves Fast Track
At 3:28 a.m. Saturday, with senior members of Congress decrying the legislation before them as a "fraud" and a "hoax," the United States House of Representatives voted by a razor-...
Jul 27, 2002 / John Nichols
The DLC Comes to Manhattan The DLC Comes to Manhattan
This past weekend, the Democratic Leadership Council (DLC) convened a national conversation in New York City.
Jul 26, 2002 / Robert L. Borosage
Mount Rushmore Mount Rushmore
Mount Rushmore, conceived in the 1920s as a tourist attraction, was quickly recast by the sculptor as an icon of democracy, freedom and hope.
Jul 26, 2002 / Feature / Jesse Larner
What Are They Reading? What Are They Reading?
Roane Carey has edited two collections of writings on the Middle East: The New Intifada (Verso, 2001) and The Other Israel (The New Press, 2002).
Jul 25, 2002 / Books & the Arts / Roane Carey
Big Pharma, Bad Science Big Pharma, Bad Science
In June, the New England Journal of Medicine, one of the most respected medical journals, made a startling announcement.
Jul 25, 2002 / Feature / Nathan Newman